
Brazilian national with an academic background in biomedical science and molecular biology. I hold a bachelor’s degree in biomedical science, a master’s in biomedical science and biotechnology from UJAEN-Spain, and a master’s in molecular biology from UFRGS-Brazil. My experience includes 6 years of laboratory analysis in molecular genetics at HCPA-Brazil, and in molecular virology at St. Thomas’ Hospital and GOSH in London. I have worked with non-coding RNAs, DNA and RNA extraction, qPCR, Ion Torrent Next-Generation Sequencing, Illumina, and bioinformatics.
My passion for biomedical research stems from a deep curiosity about molecular mechanisms in health and disease. Working in molecular genetics and virology, I witnessed how NGS impacts diagnostics, reinforcing my dedication to this field. I chose to pursue a PhD at UWA because its strong research innovation aligns with my goal of advancing science and improving diagnostics. Presenting research, training others, and developing new methodologies have strengthened my commitment, and I am eager to contribute to groundbreaking discoveries in molecular biology at UWA.
My current research project focuses on using transcriptomics approaches to investigate the molecular mechanisms underlying cannabinoid effects. By utilizing next-generation sequencing (NGS), this study profiles gene expression changes in response to cannabinoid treatment across different tissues and cell types. The primary objective is to identify genomic and transcriptional signatures associated with specific cannabinoid classes and mechanisms of action. Additionally, this research explores the potential of transcriptomics data in predicting drug safety and efficacy, integrating it with other omics data to provide a comprehensive view of drug responses. By uncovering molecular markers linked to cannabinoid efficacy and toxicity, these findings could contribute to more precise and personalized medicine. Integrating transcriptomics with multi-omics data has the potential to optimize drug discovery, enhance regulatory decision-making, and improve pharmaceutical development. A deeper understanding of how cannabinoids affect gene expression can lead to safer and more effective therapeutic applications. Ultimately, this study aims to support more informed therapeutic strategies, benefiting the scientific community, healthcare professionals, and public health by advancing knowledge in cannabinoid pharmacology and personalized medicine.
Through this research, I aim to uncover the molecular mechanisms underlying cannabinoid effects by identifying genomic and transcriptional signatures linked to their efficacy and toxicity. By integrating transcriptomics with other omics data, I seek to refine predictive models for drug safety, contributing to more precise and personalized medicine. My goal is to enhance drug discovery and regulatory decision-making, improving therapeutic applications and patient safety. UWA provides the ideal environment to achieve these objectives, offering innovative sequencing technologies, computational resources, and interdisciplinary expertise. The centre’s strong focus on drug discovery, molecular biology, and bioinformatics will support the development of my analytical skills while fostering collaboration with leading experts. Access to state-of-the-art facilities and mentorship in transcriptomics and pharmacogenomics will enable me to integrate multi-omics approaches effectively. This environment will be key to achieving my long-term goal of advancing precision medicine and drug safety research.
A fun fact about me is that my precision in the lab carries over to daily life—I instinctively measure everything, from perfectly pipetting ingredients while cooking to organizing tasks with scientific accuracy. Whether in research or daily routines, I love structure, efficiency, and a touch of molecular-level perfection 🙂